Preferred Buyer Location All Countries Except India
Demega formulations India is prime exporter of CellCept (mycophenolate mofetil) used with other medications to help prevent transplant organ rejection (attack of the transplanted organ by the immune system of the person receiving the organ) in people who have received kidney, heart, and liver transplants.